341 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
, any other business entity and any Governmental Entity.
“Post-Preference-Satisfaction Pro Rata Share” means, with respect to any given Stockholder … the Closing. It is intended that each Post-Preference-Satisfaction Pro Rata Share will be equal to the quotient of the number of shares of outstanding Company
8-K
EX-99.2
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
18 May 18
Ligand Prices Offering of $650 Million of Convertible Senior Notes
8:10am
between Ligand and the initial purchasers. Prior to November 15, 2022, the notes will be convertible only upon satisfaction of certain conditions … the proposed offering at the anticipated size or on the anticipated terms, or at all; and the satisfaction of closing conditions related
8-K
EX-99.1
5z1ol9s3i6fs t9pi
18 May 18
Ligand Prices Offering of $650 Million of Convertible Senior Notes
8:10am
CORRESP
wlpq46
16 Sep 20
Correspondence with SEC
12:00am
S-3ASR
EX-4.3
9osefyugpm00w 0em
30 Sep 22
Automatic shelf registration
4:17pm
S-1
EX-5.1
9vnhn3 esyzk
26 Sep 97
IPO registration
12:00am
SC TO-T
EX-99
f2w3cwn yu2zye
31 Aug 20
Third party tender offer statement
8:46am
CORRESP
sjgkkycwmp7a djcm
17 Nov 08
Correspondence with SEC
12:00am
S-4
mfcd z6f2qmc
9 Jul 98
Registration of securities issued in business combination transactions
12:00am
8-K
458x9ln
7 Feb 12
Departure of Directors or Certain Officers
12:00am
S-3
EX-5.1
yj6oeczsmki3
25 Sep 96
Shelf registration
12:00am